About

Sano Women's Health is a clinical-stage company dedicated to developing new chemical entities to provide effective treatments for individuals with unmet medical needs. Among its developments are novel agents aimed at mitigating the burden of multidrug-resistant infectious diseases and cancer. Additionally, Sano Women's Health is pioneering the development of first-in-class antibacterial agents with dual mechanisms of action, targeting bacteria that have developed resistance to current antibiotics.

One of its key initiatives involves the development of a drug product containing the antifungal Occidiofungin, intended to serve as a cure for recurrent vulvovaginal candidiasis.